Cite

    Mateos, M. et al. (2020). The effects of different schedules of bortezomib, melphalan, and prednisone for patients with newly diagnosed multiple myeloma who are transplant ineligible: a matching-adjusted indirect comparison. Leukemia & lymphoma. 61 (3), pp. 680-690. [Online].